INTRODUCTION
Localized extracellular proteolysis mediated by the plasminogen activation system plays an essential role in inflammation, trophoblast implantation, tissue remodeling and development, as well as in tumor invasion and metastasis (1) (2) (3) . Plasminogen activators (PA's) convert the proenzyme plasminogen into plasmin, a serine protease that activates procollagenase and, in cooperation with collagenase and elastase, contributes to the degradation of the extracellular matrix. PA activity is regulated by the plasminogen activator inhibitors (PAI's): PAI-1 and PAI-2. PAI-1 binds to the extracellular matrix and is a very efficient inhibitor of both tissue-type (t-PA) and urinary-type PA (u-PA), whereas PAI-2 rapidly inhibits u-PA and also reacts with two chain t-PA (4, 5) . The binding of pro-u-PA and plasminogen to specific cell-surface receptors (6) and their subsequent activation (7) localizes proteolytic activity to the cell surface and contributes to the invasive potential of human monocytes (8) , of keratinocytes (9) and of tumor cells (10, 11) . Both PAI's react with receptorbound u-PA and may play a role in the regulation of matrix degradation by invasive cells (12 -15) . The biosynthesis of both inhibitors is regulated by a variety of hormones, growth factors and cytokines. PAI-2 is induced by endotoxin in human and mouse macrophages (16, 17) and in human monocytes (18, 19) , by the tumor-promoting phorbol 12-myristate 13-acetate (PMA) in monocyte-like (U-937) cells (4, 20, 21) and in human umbilical vein endothelial cells (22) , by tumor necrosis factor alpha in human HT1080 fibrosarcoma cells (23) and endothelial cells (22) . PAI-2 expression is furthermore induced by cholera toxin (an activator of adenylate cyclase) in cultured mouse macrophages (24) and by Dengue virus in cultured monocytes (25) , whereas in HT1080 cells and mouse macrophages the biosynthesis of PAI-2 mRNA is suppressed by dexamethasone (24, 26) . The transcriptional induction of PAI-2 by tumor necrosis factor or PMA, and also its inhibitory effect on receptor bound u-PA, suggest that PAI-2 is an important regulator of pericellular proteolysis in inflammatory processes.
We have previously isolated and sequenced 2kb of the PAI-2 gene promoter (27) . To functionally characterize this promoter, deletion constructs fused to the CAT reporter gene were transiently expressed in human HT1080 fibrosarcoma cells. Measurements of CAT activities, as well as DNAse I protection analyses and site-specific mutagenesis, enabled us to identify three functional regulatory elements, two activator protein-1-like (API-like) and one motif resembling the c-AMP responsive element-like (CRE-like).
MATERIALS AND METHODS

Cell culture
Human HT1080 fibrosarcoma cells (American Type Culture Collection, Rockville, MD) were cultured to confluency according to standard techniques in 50 ml of Dulbecco's modified Eagle's Medium (DMEM) supplemented with 2mM glutamine (Biomerieux, Marcy, France) and 10% of heat-inactivated fetal calf serum (FCS, Gibco, Paisley, UK) at 37°C using 150 cm 2 culture flasks (Corning Glass Works, Corning, NY). Cells were serum starved overnight before the start of an experiment.
Northern blot analysis HT1080 cells were incubated with either fresh serum-free DMEM alone or with medium supplemented with 25 ng/ml PMA (Sigma, St. Louis, Mo, USA) for 24 h. Cells were harvested and poly A + selected RNA prepared by affinity adsorption on oligo d(T) cellulose as previously described (28, 29) . Electrophoresis in 0.95% agarose in the presence of 20% formaldehyde followed by Northern blot transfer was performed as described by Thomas (30) , but using Gene Screen Plus membranes (New England Nuclear, Boston, MA). PAI-2 mRNA levels were determined by hybridization to a human PAI-2 cDNA probe (21) labeled with alpha [ 32 P] dATP, using the Random Primed DNA labeling kit (Boehringer Mannheim, Germany), to a specific activity of approximately 100 /tCi/jig. Hybridization conditions and processing of filters were as previously described (29) . Exposure times of filters to X-ray film (Kodak, Lausanne, Switzerland) were chosen to visually optimize the signal. As an internal control, filters were subsequently probed with a mouse /3-actin cDNA probe (31) , obtained from Dr. S. Petrucco (ISREC, Epalinges, Switzerland).
Run-on transcription assay HT1080 cells were cultured for 24 h in fresh serum-free DMEM with or without 25 ng/ml PMA. Cell harvesting, nuclei isolation, elongation and labeling of initiated RNA transcripts, was performed using a modified (26) method of Greenberg and Ziff (32) . Approximately 2xlO 7 nuclei and 100/tCi of alpha [ 32 P] UTP (specific activity of 3000 Ci/mmol) were used for each reaction. Filter strips containing 2jtg of slotted p38 PAI-2 genomic DNA (27) or mouse /3-actin cDNA, were hybridized with the labeled RNA transcripts for 36 h at 65°C, then washed, RNase treated, air dried and exposed to X-ray film for up to 9 days with an intensifying screen(32).
PAI-2 promoter deletion constructs
The deletion mutants used in this study were obtained either by polymerase chain reaction (PCR) methodology, using the genomic p52 PAI-2 clone (27) as a template, or by digestion of the PCR derived constructs with appropriate restriction enzymes. All constructs were verified by DNA sequencing (33) .
The -1063pUC, -428pUC, -215pUC and -91pUC constructs were obtained by PCR, using the primers: T5' CATA-TCTAGATCACATAGACATTACCAGA 3'; 5' ATGCCCT-AAGCATCGCTTGG 3'; 5' CAGGCATGTCTAGATATT-GAC 3'; and 5' CCATATCTAGAGGACACAGATCAAAAG-ACAGA 3', respectively, in combination with the primer 5' ACATGGATCCTCTTGAGACCTGAGTTGCTGTCTG-ACGG 3' (ending at position +43). The amplified fragments (-1063, -215, -91bp) were digested with Xba I and BamH I (underlined on the primer sequences) and inserted between the Xba I and BamH I sites of pUC18. Xba I linkers were added to the -428 bp amplified fragment and the product subcloned into the Xba I site of pUC18. The -904pUC construct was derived from -1063 pUC by complete EcoR I and partial Bgl II digestions. The fragment, containing the first 904 bp up-stream the transcription initiation site, was cloned into the BamH 1-EcoR I sites of pUC18.
The AAlupUC construct was derived from -1063 pUC, by removing a 321 bp Bgl U-Bgl II fragment (-905 to -578), containing a complete Alu (proximal) repeated sequence.
The -339pUC construct was derived from -428 pUC by digestion with Sal I and Nco I, followed by Klenow 'fill in' and self religation.
Promoter segments of all PAI-2 pUC constructs were isolated by digestion with Hind m and BamH I, gel purified and subcloned into the promoterless pBLCAT3 plasmid (Luckow and Schiitz,1987) upstream the Chloramphenicol Acetyl Transferase (CAT) reporter gene.
The -1839CAT construct containing two Alu repeated sequences was made in two steps: first, a 3 kb Hind Ul-Afl II insert was excised from the p52 genomic plasmid and cloned into the Hind Ul-Afl II sites of -1063 pUC, generating a -33OOpUC construct. Second, a 1,9 Kb Xba 1-BamH I insert was isolated from this intermediate construct and transferred into pBLCAT3.
As shown in Figure 2 , each construct contains the first 43 bp of exon 1 directly fused to the CAT reporter gene.
DNA transfections
The day before transfection 0.5 x 10 6 HT1080 cells were plated on 60 mm 2 dishes (Falcon, Becton Dickinson, New Jersey) in 5 ml DMEM containing 10% FCS and 2mM glutamine, and grown overnight. Cells were transfected with 10 /ig of DNA (PAI-2 promoter CAT constructs) by the calcium phosphate precipitation method (34, 35) . As positive and negative controls, 10 fig of pRSVCAT (36) and pBLCAT3 (37) were used, respectively. A glycerol shock (2 minutes) was performed 4 hours later and cells were maintained overnight in fresh medium. The next day, transfected cells were washed and incubated overnight either in serum-free medium (controls), or in serum-free medium supplemented with 25 ng/ml PMA. After 24 h incubation, cells were harvested, washed in PBS, resuspended' in 100 \i\ of Tris buffer, and lysed by three freeze-thaw cycles. After centrifugation, the supernatants containing the cytoplasmic extracts were collected and kept at -20°C or immediately used for the analysis of CAT expression (35) . 
DNase I protection assay
Nuclear protein extracts were prepared from HT1080 cells cultured in serum-free medium. Isolated nuclei (26) were mechanically broken and proteins were precipitated with ammonium sulfate at 50% saturation prior to overnight dialysis (38) •" I I CAT samples were processed as described previously (40) and -3000 cpm of each sample were loaded on a 6% sequencing gel. Sequencing reactions (33) of both strands were made simultaneously and run in parallel.
Construction of site-specific mutants
To generate specific base mutations in the promoter, the insert of the -1063 pUC construct was transferred into the M13mpl8 vector (New England Biolabs, Schwalbach, FRG). Selective base substitutions of the API-like sites and the CRE-like element were made using the Mutagene® protocol (Bio-Rad, Richmond CA, USA) and synthetic oligomers (Fig.5 ). Mutants were selected as described by Kunkel (41) , using a dut~, ung~ Escherichia Coli strain, and cloned into pBLCAT3. The new chimaeric genes were confirmed by DNA sequence (42) . The mutant constructs were transiently expressed in HT1080 cells, using the wild-type -1063CAT construct as a control. Transfected cells were incubated with serum-free medium alone or with 25 ng/ml PMA, and harvested after 24 h. Cellular extracts were assessed for CAT expression as described above.
RESULTS
Induction of PAI-2 mRNA and gene transcription by PMA
To investigate the possible modulation of PAI-2 by PMA, human HT1080 fibrosarcoma cells were incubated in either fresh medium alone or supplemented with PMA (25 ng/ml) for 24 h. PMA treatment resulted in an induction of mRNA expression (Fig. 1 , top panel) and gene transcription (Fig.l, bottom panel) . Induction was selective as no changes in jS-actin mRNA levels or /3-actin gene transcription rate were observed in the presence of PMA over the same time period.
Transfection experiments with deletion mutants
To localize the promoter regions involved in basal and PMAinduced transcription, deletion mutants of the PAI-2 promoter (Fig.2) fused to the CAT reporter gene, were transiently expressed in HT1080 cells. Basal CAT activities were constitutively expressed by all deletion mutants containing 215 bp or more of promoter sequence (Fig.3) , whereas constructs shortened to position -91 produced no detectable basal CAT activity.
The difference in CAT activity between the -215 and the -91 constructs was significant (p<0.05 ; Wilcoxon signed-rank test).
Treatment for 24 h with PMA, produced a 3 -10 fold increase in CAT activity from deletion mutants containing 215 bp or more of promoter sequence, whereas the construct shortened to -91 did not respond to phorbol ester treatment. These results indicate that essential elements for basal expression and phorbol estermediated induction lie between -215 and -91.
The PAI-2 promoter contains two Alu repeat sequences (Fig.2) , mobile DNA elements that might influence gene expression (43, 44) . As basal and PMA induced CAT activity produced by the AAluCAT construct was similar to that of the -1063CAT construct (one Alu repeat) and the -1839CAT construct (two Alu repeats), we may conclude that the AJu sequences in the PAI-2 promoter do not significally influence PAI-2 gene expression.
DNase I protection assay
To identify possible protein binding sites between positions -215 and -91, as well as potentially important cis-acting elements downstream of -91, a DNase I protection (footprint) assay was performed using the -259/+43 construct (Fig.4) . Footprint analysis revealed several protected regions, most of them present on both DNA strands: 1) -37 to -30 and -24 to -20 (AAGCTGTATAAAACC-AGT) which surrounds the TATA A box (underlined);
2) -67 to -42 (GAGAAAAAAAAATGCCATGTGGG-AGG) contains part of an SPl-like site (underlined) (45) No significant differences in the pattern of protection were observed when DNase I protection was performed using extracts prepared from PMA-treated cells ( data not shown).
Transfection of site-specific mutants
As footprint and sequence analysis confirmed the presence of three potential cis-acting elements,-two API-like sites (APla and APlb), and one CRE-like site-, which are known to
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AT C -+ + - modulate gene expression in other systems, these sites were mutated using oligomers (Fig. 5, panel A) . The site-specific mutants, derived from the wild type -1063 construct, were transiently expressed into HT1080 cells and their CAT activities compared to that of the wild type. TheCRE, APlaand APla + b mutants produced undectable basal CAT activities, whereas basal expression generated from the APlb construct was reduced but still detectable (Fig. 5, panel B) . After PMA stimulation, only the APlb mutant, partially protected in the footprint analysis (Fig. 4) , showed an increase in CAT activity. (46) , whereas API elements convey PMA responsiveness (47) and act as binding sites for a family of transcription factors which include c-fos and c-jun. Interestingly, the CRE-like element (TGACA; TCA) in the promoter of the c-jun proto-oncogene acts as a high affinity API-binding site (48) . The same sequence is found in the human t-PA gene and is required for PMA-induced transcription (40) . The CRE-like element (TGACCTCA) in the PAI-2 promoter differs from the CRE consensus sequence (TGACGTCA) at the same position as the CRE's in the c-jun and t-PA genes. These observations imply that the APla and CRE-like sites mediate, at least in part, the PMA response. However, at present we cannot exclude the possibility that other cryptic elements contribute to the phorbol ester response of the PAI-2 gene.
DISCUSSION
Mutagenesis of the APlb element was less effective in that basal expression and PMA-inducible expression was only partially reduced. This is interesting in light of our observation that the protected region between -110 and -91, which completely covers the APla site, only partially protects (2bp) the APlb site. Although mutation of the APlb site led to a reduced constitutive activity, we cannot discount the possibility that this is due to the modification of important sequences flanking the APla element. Similarly, other elements downstream of position -215 could also contribute to this response. The protected regions flanking either side of the TATA box are likely to play some role. Further investigations are needed to determine a possible contribution of these particular sites and the other protected regions in the regulation of the PAI-2 promoter.
The PAI-2 promoter contains two Alu inverted repeated sequences between -1390 and -1100 (distal) and between -870 and -580 (proximal). A recent report demonstrated that some Alu sequences may contain a negative regulatory element (44) . To investigate the presence of such an element, we compared promoter constructs containing either no Alu sequence (AAlu), one Alu sequence (-1063CAT), or two Alu repeats (-1839CAT). The similar CAT activities generated from each of these constructs suggest that the Alu sequences in the PAI-2 promoter do not contain such a repressor element.
In this study, we have performed a functional analysis of the PAI-2 promoter and have identified a CRE-like element and an API-like binding site which are essential for constitutive expression, and which may also be required for phorbol ester inducibility. The PAI-2 gene is also transcriptionally responsive to the inflammatory cytokine, tumor necrosis factor (TNF) in HT1080 cells (23) . Experiments are being undertaken to determine the possible role of these elements during TNFmediated expression.
